Nuveen’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $91.2M | Buy |
465,425
+131,391
| +39% | +$25.5M | 0.02% | 420 |
|
|
2025
Q4 | $58M | Sell |
334,034
-4,213
| -1% | -$767K | 0.02% | 568 |
|
|
2025
Q3 | $64.5M | Sell |
338,247
-980
| -0.3% | -$174K | 0.02% | 529 |
|
|
2025
Q2 | $60.9M | Buy |
339,227
+10,697
| +3% | +$1.86M | 0.02% | 533 |
|
|
2025
Q1 | $55.6M | Buy |
328,530
+2,129
| +0.7% | +$350K | 0.02% | 585 |
|
|
2024
Q4 | $49.2M | Sell |
326,401
-15,772
| -5% | -$2.45M | 0.01% | 655 |
|
|
2024
Q3 | $53.1M | Sell |
342,173
-5,481
| -2% | -$819K | 0.01% | 626 |
|
|
2024
Q2 | $47.6M | Sell |
347,654
-13,157
| -4% | -$1.8M | 0.01% | 648 |
|
|
2024
Q1 | $47.9M | Buy |
360,811
+17,620
| +5% | +$2.29M | 0.01% | 650 |
|
|
2023
Q4 | $47.3M | Sell |
343,191
-30,802
| -8% | -$4.05M | 0.02% | 626 |
|
|
2023
Q3 | $45.6M | Sell |
373,993
-20,433
| -5% | -$2.72M | 0.02% | 598 |
|
|
2023
Q2 | $55.4M | Sell |
394,426
-2,049
| -0.5% | -$282K | 0.02% | 546 |
|
|
2023
Q1 | $56.1M | Buy |
396,475
+28,038
| +8% | +$4.01M | 0.02% | 507 |
|
|
2022
Q4 | $57.6M | Sell |
368,437
-14,389
| -4% | -$2.07M | 0.02% | 495 |
|
|
2022
Q3 | $47M | Sell |
382,826
-2,783
| -0.7% | -$367K | 0.02% | 543 |
|
|
2022
Q2 | $51.3M | Sell |
385,609
-11,075
| -3% | -$1.51M | 0.02% | 545 |
|
|
2022
Q1 | $57.1M | Sell |
396,684
-215,100
| -35% | -$30M | 0.02% | 586 |
|
|
2021
Q4 | $106M | Sell |
611,784
-42,199
| -6% | -$6.42M | 0.03% | 419 |
|
|
2021
Q3 | $95M | Sell |
653,983
-106,259
| -14% | -$15.5M | 0.03% | 441 |
|
|
2021
Q2 | $100M | Sell |
760,242
-4,587
| -0.6% | -$601K | 0.03% | 476 |
|
|
2021
Q1 | $98.2M | Sell |
764,829
-295,432
| -28% | -$36.4M | 0.03% | 470 |
|
|
2020
Q4 | $126M | Buy |
1,060,261
+144,373
| +16% | +$17.6M | 0.04% | 376 |
|
|
2020
Q3 | $105M | Sell |
915,888
-802,684
| -47% | -$94.8M | 0.04% | 364 |
|
|
2020
Q2 | $196M | Buy |
1,718,572
+984,331
| +134% | +$104M | 0.08% | 227 |
|
|
2020
Q1 | $59M | Buy |
734,241
+227,707
| +45% | +$23.6M | 0.03% | 447 |
|
|
2019
Q4 | $54.1M | Sell |
506,534
-42,806
| -8% | -$4.46M | 0.02% | 633 |
|
|
2019
Q3 | $58.8M | Buy |
549,340
+126,691
| +30% | +$13M | 0.02% | 585 |
|
|
2019
Q2 | $43M | Buy |
422,649
+418,732
| +10,690% | +$40.2M | 0.02% | 754 |
|
|
2019
Q1 | $352K | Hold |
3,917
| – | – | ﹤0.01% | 898 |
|
|
2018
Q4 | $326K | Buy |
3,917
+70
| +2% | +$6.56K | ﹤0.01% | 879 |
|
|
2018
Q3 | $415K | Sell |
3,847
-6
| -0.2% | -$658 | ﹤0.01% | 899 |
|
|
2018
Q2 | $424K | Hold |
3,853
| – | – | ﹤0.01% | 896 |
|
|
2018
Q1 | $386K | Sell |
3,853
-2
| -0.1% | -$205 | ﹤0.01% | 938 |
|
|
2017
Q4 | $380K | Sell |
3,855
-7
| -0.2% | -$664 | ﹤0.01% | 948 |
|
|
2017
Q3 | $362K | Sell |
3,862
-12
| -0.3% | -$1.27K | ﹤0.01% | 968 |
|
|
2017
Q2 | $431K | Sell |
3,874
-4,430
| -53% | -$468K | ﹤0.01% | 967 |
|
|
2017
Q1 | $815K | Sell |
8,304
-51,739
| -86% | -$4.93M | ﹤0.01% | 1031 |
|
|
2016
Q4 | $5.52M | Buy |
+60,043
| New | +$5.18M | 0.03% | 600 |
|
|
2016
Q2 | – | Sell |
-9,060
| Closed | -$647 | – | 1335 |
|
|
2016
Q1 | $647 | Hold |
9,060
| – | – | ﹤0.01% | 1167 |
|
|
2015
Q4 | $645 | Sell |
9,060
-314
| -3% | -$21.1K | ﹤0.01% | 1216 |
|
|
2015
Q3 | $576 | Sell |
9,374
-236
| -2% | -$16.5K | ﹤0.01% | 1284 |
|
|
2015
Q2 | $697 | Hold |
9,610
| – | – | ﹤0.01% | 1282 |
|
|
2015
Q1 | $739K | Hold |
9,610
| – | – | ﹤0.01% | 1268 |
|
|
2014
Q4 | $644K | Sell |
9,610
-200
| -2% | -$12.6K | ﹤0.01% | 1323 |
|
|
2014
Q3 | $595K | Hold |
9,810
| – | – | ﹤0.01% | 1308 |
|
|
2014
Q2 | $576K | Sell |
9,810
-403
| -4% | -$23.6K | ﹤0.01% | 1334 |
|
|
2014
Q1 | $592K | Sell |
10,213
-1,335
| -12% | -$71.6K | ﹤0.01% | 1314 |
|
|
2013
Q4 | $618K | Sell |
11,548
-782
| -6% | -$46.4K | ﹤0.01% | 1259 |
|
|
2013
Q3 | $762K | Buy |
12,330
+240
| +2% | +$14.4K | ﹤0.01% | 1217 |
|
|
2013
Q2 | $733K | Buy |
+12,090
| New | +$720K | ﹤0.01% | 1165 |
|
Other funds holding DGX
VCM
VPM
EIG
Nuveen's DGX Position: Q1 2026 in Review
Nuveen increased its Quest Diagnostics (DGX) stake by 39% in Q1 2026, buying an estimated $25.5M and bringing the position to 465,425 shares worth $91.2M. The position accounts for 0.02% of the portfolio, ranked #420.
Nuveen first reported a position in DGX in Q2 2013 and has held it in 50 quarters since. The position peaked at $196M in Q2 2020. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Nuveen held 465,425 shares of Quest Diagnostics worth $91.2M as of Q1 2026.
- Nuveen bought 131,391 Quest Diagnostics shares in Q1 2026, an estimated $25.5M.
- Quest Diagnostics made up 0.02% of Nuveen's portfolio in Q1 2026, its #420 holding.
- Nuveen first reported a position in Quest Diagnostics in Q2 2013 and has held it in 50 quarters since.
- Nuveen's Quest Diagnostics position peaked at $196M in Q2 2020.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.